BeOne Medicines (BEIGF) Net Income towards Common Stockholders Growth (1y) (2016 - 2026)
BeOne Medicines (BEIGF) Net Income towards Common Stockholders Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
-58.11% |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
104.24% |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
-129.68% |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
-290.15% |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
17,802.13% |
| Date | Value |
|---|
| Mar 31, 2026 |
17,802.13% |
| Dec 31, 2025 |
143.79% |
| Sep 30, 2025 |
202.88% |
| Jun 30, 2025 |
178.34% |
| Mar 31, 2025 |
100.51% |
| Dec 31, 2024 |
58.68% |
| Sep 30, 2024 |
-156.33% |
| Jun 30, 2024 |
68.41% |
| Mar 31, 2024 |
27.92% |
| Dec 31, 2023 |
17.47% |
| Sep 30, 2023 |
138.64% |
| Jun 30, 2023 |
32.63% |
| Mar 31, 2023 |
19.94% |
| Dec 31, 2022 |
24.61% |
| Sep 30, 2022 |
-27.26% |
| Jun 30, 2022 |
-17.78% |
| Mar 31, 2022 |
-754.48% |
| Dec 31, 2021 |
-17.97% |
| Sep 30, 2021 |
-0.55% |
| Jun 30, 2021 |
-38.62% |
